Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionDavis R M Inc
Latest Disclosed Ownership4,245 shares
Latest Disclosed Value $ 257,460
Davis R M Inc ownership in BRM / Bristol-Myers Squibb Company

On May 13, 2026 - Davis R M Inc filed a 13F-HR form disclosing ownership of 4,245 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $222,523 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 12, 2025 disclosing 0 shares of Bristol-Myers Squibb Company. The current value of the position is $201,362 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,245 4,245 257 0.0046
2025-11-12 2025-09-30 13F Bristol-Myers Squibb COM 110122108 0 -4,326 -100.00 0 -100.00
2025-08-07 2025-06-30 13F Bristol-Myers Squibb COM 110122108 4,326 -3,178 -42.35 200 -56.24 0.0037
2025-05-08 2025-03-31 13F Bristol-Myers Squibb COM 110122108 7,504 1,674 28.71 458 38.91 0.0092
2025-02-07 2024-12-31 13F Bristol-Myers Squibb COM 110122108 5,830 -1,065 -15.45 330 -7.58 0.0064
2024-11-13 2024-09-30 13F Bristol-Myers Squibb COM 110122108 6,895 -2,474 -26.41 357 -8.48 0.0069
2024-08-09 2024-06-30 13F Bristol-Myers Squibb COM 110122108 9,369 225 2.46 389 -21.41 0.0079
2024-05-10 2024-03-31 13F Bristol-Myers Squibb COM 110122108 9,144 -145 -1.56 496 3.99 0.0104
2024-02-09 2023-12-31 13F Bristol-Myers Squibb COM 110122108 9,289 -1,223 -11.63 477 0.0110
2023-11-14 2023-09-30 13F Bristol-Myers Squibb COM 110122108 10,512 -1,371 -11.54 1 0.0153
2023-08-10 2023-06-30 13F Bristol-Myers Squibb COM 110122108 11,883 1,289 12.17 1 0.0183
2023-05-01 2023-03-31 13F Bristol-Myers Squibb COM 110122108 10,594 65 0.62 1 0.0187
2023-02-14 2022-12-31 13F Bristol-Myers Squibb COM 110122108 10,529 590 5.94 1 -100.00 0.0204
2022-11-08 2022-09-30 13F Bristol-Myers Squibb COM 110122108 9,939 100 1.02 707 -6.73 0.0205
2022-08-08 2022-06-30 13F Bristol-Myers Squibb COM 110122108 9,839 958 10.79 758 16.80 0.0211
2022-05-05 2022-03-31 13F Bristol-Myers Squibb COM 110122108 8,881 638 7.74 649 26.26 0.0155
2022-02-08 2021-12-31 13F Bristol-Myers Squibb COM 110122108 8,243 -1 -0.01 514 5.33 0.0115
2021-11-08 2021-09-30 13F Bristol-Myers Squibb COM 110122108 8,244 -282 -3.31 488 -14.39 0.0121
2021-08-12 2021-06-30 13F Bristol-Myers Squibb COM 110122108 8,526 585 7.37 570 13.77 0.0143
2021-05-10 2021-03-31 13F Bristol-Myers Squibb COM 110122108 7,941 -1,885 -19.18 501 -17.87 0.0138
2021-01-27 2020-12-31 13F Bristol-Myers Squibb COM 110122108 9,826 354 3.74 610 6.83 0.0175
2020-12-01 2020-09-30 13F Bristol-Myers Squibb COM 110122108 9,472 -1,428 -13.10 571 -10.92 0.0187
2020-07-20 2020-06-30 13F Bristol-Myers Squibb COM 110122108 10,900 -1,162 -9.63 641 -4.61 0.0228
2020-04-24 2020-03-31 13F Bristol-Myers Squibb COM 110122108 12,062 266 2.26 672 -11.23 0.0279
2020-01-23 2019-12-31 13F Bristol-Myers Squibb COM 110122108 11,796 -598 -4.82 757 20.54 0.0248
2019-10-24 2019-09-30 13F Bristol-Myers Squibb COM 110122108 12,394 -548 -4.23 628 6.98 0.0221
2019-07-31 2019-06-30 13F Bristol-Myers Squibb COM 110122108 12,942 -1,151 -8.17 587 -12.65 0.0209
2019-04-29 2019-03-31 13F Bristol-Myers Squibb COM 110122108 14,093 -275 -1.91 672 -10.04 0.0250
2019-01-18 2018-12-31 13F Bristol-Myers Squibb COM 110122108 14,368 -2,720 -15.92 747 -29.59 0.0306
2018-10-17 2018-09-30 13F Bristol-Myers Squibb COM 110122108 17,088 -229 -1.32 1,061 10.75 0.0385
2018-07-19 2018-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,317 -2,618 -13.13 958 -24.03 0.0373
2018-04-19 2018-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,935 -1,242 -5.86 1,261 -2.85 0.0503
2018-01-16 2017-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,177 -800 -3.64 1,298 -7.35 0.0509
2017-10-24 2017-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,977 1,549 7.58 1,401 23.11 0.0579
2017-07-31 2017-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,428 -7,250 -26.19 1,138 -24.39 0.0481
2017-05-03 2017-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 27,678 -1,729 -5.88 1,505 -12.45 0.0680
2017-01-18 2016-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 29,407 6,820 30.19 1,719 41.13 0.0821
2016-10-19 2016-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 22,587 -433 -1.88 1,218 -28.06 0.0594
2016-07-14 2016-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 23,020 1,600 7.47 1,693 23.76 0.0832
2016-04-18 2016-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,420 259 1.22 1,368 -6.04 0.0696
2016-01-14 2015-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,161 -887 -4.02 1,456 11.57 0.0745
2015-10-16 2015-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 22,048 386 1.78 1,305 -9.44 0.0697
2015-07-16 2015-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,662 2,872 15.28 1,441 18.89 0.0744
2015-04-17 2015-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,790 -651 -3.35 1,212 5.57 0.0638
2015-01-23 2014-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,441 900 4.85 1,148 20.97 0.0633
2014-10-20 2014-09-30 13F/A-2 BRISTOL-MYERS SQUIBB COM 110122108 18,541 -1,875 -9.18 949 -4.14 0.0545
2014-10-20 2014-09-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 18,541 0 949 0.0545
2014-10-20 2014-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,416 990
2014-07-15 2014-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,416 5,232 34.46 990 25.48 0.0569
2014-04-15 2014-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,184 -1,633 -9.71 789 -11.74 0.0479
2014-01-27 2013-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 16,817 1,154 7.37 894 23.31 0.0547
2013-10-23 2013-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 15,663 -1,799 -10.30 725 -7.05 0.0489
2013-08-12 2013-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 17,462 17,462 780 0.0556
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.